期刊文献+

阿司匹林预防和治疗大鼠骨质疏松的实验研究 被引量:5

Study of the Prevention and Treatment Effect on Female Osteoporotic Mice with Aspirin
下载PDF
导出
摘要 目的观察阿司匹林对于趋势大鼠骨质疏松的影响,探究不同剂量及不同时期口服阿司匹林对骨质疏松的辅助治疗作用。方法取42只6个月龄的雌性wistar大鼠,随机选取6只作为假手术组(A),余36只作为去势组。去势组分为阿司匹林预防组:去势对照组(B),去势阿司匹林(8.92 mg/kg)组(C),去势阿司匹林(26.75 mg/kg)组(D)和阿司匹林治疗组:去势对照(E),阿司匹林(8.92 mg/kg)组(F),阿司匹林组(26.75 mg/kg)组(G)。预防组于去势后3 d给予不同剂量阿司匹林灌胃,治疗组于去势后12周灌胃。对42只大鼠双侧股骨干进行取材,对双侧股骨干行生物力学测定,右股骨干行双能X线骨密度测量观察骨密度变化。结果①骨密度:预防组B组的骨密度值较A、C、D明显下降;治疗组E组的骨密度值较A、F、G组明显下降(P<0.05)。②生物力学:预防部分与治疗部分的去势对照组较假手术组、去势8.92 mg/kg组及去势26.75 mg/kg的三点弯曲载荷显著降低(P<0.05)。预防组与治疗组同剂量间比较,预防组的最大破坏应力指标高于治疗组(P<0.05)。结论早期应用阿司匹林能增加去势大鼠的骨密度,增加骨质生物力学强度。 Objective To observe the effect of aspirin on osteoporosis and to explore the effect of different doses or different time of aspirin on adjuvant therapy after osteoporosis in ovariectomized rats. Methods Forty-Two 6-month female wistar rats were randomly divided into two groups: 6 rats in sham-operated (A) group and 36 rats in ovariestomized (OVX) group. The OVX group was divided two groups. Prevention of osteoporosis using aspirin: OVX control group (B), 8.92 mg/kg aspirin group (C), 26.75 mg/kg aspirin group (D). Treatment of osteoposis using aspirin: OVX control group (E), 8.92 mg/kg aspirin group(F), 26.75 mg/kg aspirin group (G). The rats in prevention group were given an intragastric gavage of aspirin after OVX 3 days, while the treatment groups after 12 weeks. Bilateral humerus was collected. Three-point bending eaperiment was performed on the bilateral. The right humerus tested using dual-energy X-ray absorptiometry. Result ①bone mineral (BDM): The BMD in group B was signiifcantly lower than that in group A, C, D. The BMD in group E was signiifcantly lower than that in goup A, F, G (P〈0.05). ②Three-point bending lode: The three-point bending lode in the OVX control groups was signiifcantly lower than that aspirin groups (P〈0.05). The three-point bending lode in the prevention group was higher than the treatment group of the same dose (P〈0.05). Conclusion Aspirin can obviously increase the BMD of ovariectomized osteoporotic mice, and improve the mechanical properties of the bone.
出处 《中国医药指南》 2014年第7期51-52,54,共3页 Guide of China Medicine
关键词 骨质疏松 阿司匹林 大鼠 骨密度 生物力学 Osteoporosis Aspirin Rats Bone mineral density Biomechanics
  • 相关文献

参考文献15

  • 1Consensus Development Conference.Diagnosis,prophylaxis and treatment of osteoporosis[J].Am J Med,1993,94(5):646-650.
  • 2陈志文,桑宏勋.阿司匹林治疗骨质疏松的研究进展[J].中国骨质疏松杂志,2009,15(9):703-705. 被引量:3
  • 3Ismal NM.Postmenopausal osteoporosis:epidemiology,pathophy- siology and treatment[J].My J Pathol,1997,19(1):21-25.
  • 4Thomsen K,Gotfredsen A,Christiansen C.Is post-menopausal bone loss an age-related phenomenon?[J].Calcified Tissue Int,1986,39 (3):123-127.
  • 5International Osteoporosis Foundation.Facts and statistics about osteoporosis and its impact.Inter national osteoporosis foundation [J].J Bone Mineral Res,2009,4(1): 113-118.
  • 6Carbone LD,Tylavsky FA,Cauley JA,et al.Association between bonemineral density and the use of nonsteroidal anti-inflammatorydrugs and aspirin: impact of cyclooxygenase selectivity[J].Bone Miner Res,2003,18(10):1795-1802.
  • 7赵光,杨艳萍,沈霖.替勃龙对绝经后骨质疏松症患者骨密度及骨代谢指标的影响[J].中华骨质疏松和骨矿盐疾病杂志,2012,5(1):20-24. 被引量:16
  • 8秦岭,梁国穗.骨生物力学在防治骨质疏松药物开发中的应用基础(二)[J].中国骨质疏松杂志,2000,6(2):73-78. 被引量:5
  • 9Rossouw JE,Anderson GL,Prentice RL,et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women' s health initiativer randomized controlled trial[J].J Am Med Assoe,2002,288(3):321-333.
  • 10Chlebowski RT, Hendrix SL,Langer RD,et al.Influence of estro- gen plus progestin on breast cancer and mammography in healthy postmenopansal women: the women's health initiative randomized trial[J].J Am Med Assoc,2003,289(24):3243-3253.

二级参考文献26

  • 1Katja S Rothfuss,Eduard F Stange,Klaus R Herrlinger.Extraintestinal manifestations and complications in inflammatory bowel diseases[J].World Journal of Gastroenterology,2006,12(30):4819-4831. 被引量:26
  • 2魏雅楠,苗懿德,刘忠厚,刘杰.骨代谢生化标志物的临床进展——不同国家和地区绝经前后女性骨代谢标志物参考值回顾分析[J].中国骨质疏松杂志,2007,13(7):455-468. 被引量:23
  • 3殷文娟 罗先正 等.骨质疏松症防治药物--双磷酸盐的研究进展.骨质疏松症-骨基础理论研究[M].哈尔滨出版社,1998.198-202.
  • 4冯坤 刘忠厚.骨质疏松的实验动物模型.骨质疏松学[M].科学出版社,1998.501-511.
  • 5Simon AM,Manigrasso MB,O'Connor JP. Cyclo-oxygenase 2 function is essential for bone fracture healing[J].Journal of Bone and Mineral Research,2002.963-976.
  • 6Dickens DS,Kozielski R,Leavey PJ. Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma[J].Journal of Pediatric Hematology Oncology,2003.282-285.
  • 7Ahlborg HG,Johnell O,Karlsson MK. An age-related medullary expansion can have implications for the long-term fixation of hip prostheses[J].Acta Orthopaedica Scandinavica,2004.154-159.
  • 8Ahlborg HG,Johnell O,Karlsson MK. An agerelated medullary expansion can have implications for the longterm fixation of hip prostheses[J].Acta Orthopaedica Scandinavica,2004.154-159.
  • 9Lacey JV Jr,Brinton LA,Lubin JH. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women[J].Cancer Epidemiology Biomarkers and Prevention,2005.1724-1731.
  • 10Bird TA,Saklatvala J. Identification of a common class of high affinity teceptors for both type of porcine intcrlcukin-1 on connective tissue cells[J].Nature,1986.263-267.

共引文献24

同被引文献65

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部